FDA Updates Classification Level for Recalled Blood Pressure Medicine

The medications are now categorized under a Class II designation, which is issued when using a drug can cause temporary health issues.

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration has updated the recall classification of certain blood pressure medicines sold in the United States were recalled last month.

On March 19, New Jersey-based Teva Pharmaceuticals USA, Inc. issued recalls for more than 300,000 cartons of Clonidine Transdermal System, according to FDA reports. The drugs, which treat blood pressure or hypertension, were recalled as they used an “unapproved raw material” and thus deviated from the agency’s regulations.